Hepatitis C treatment and long-term outcome of patients with hepatocellular carcinoma after resection

This study aimed to investigate the survival outcomes of antiviral agents (direct-acting antivirals [DAAs] or interferon [IFN]) in patients with hepatitis C virus who underwent liver resection for primary hepatocellular carcinoma.

Subjects

direct-acting antiviral therapy; hepatectomy; hepatitis C virus; hepatocellular carcinoma; interferon; outcome; survival